Literature DB >> 26556058

Telemedicine in the acute health setting: A disruptive innovation for specialists (an example from stroke).

Kathleen L Bagot1, Dominique A Cadilhac2, Michelle Vu3, Karen Moss3, Christopher F Bladin2.   

Abstract

INTRODUCTION: Telemedicine is a disruptive innovation within health care settings as consultations take place via audio-visual technology rather than traditional face-to-face. Specialist perceptions and experiences of providing audio-visual consultations in emergency situations, however, are not well understood. The aim of this exploratory study was to describe the experience of medical specialists providing acute stroke decision-making support via telemedicine.
METHODS: Data from the Victorian Stroke Telemedicine (VST) programme were used. The experiences of specialists providing an acute clinical telemedicine service to rural emergency departments were explored, drawing on disruptive innovation theory. Document analysis of programme consultation records, meeting minutes and in-depth individual interviews with three neurologists were analysed using triangulation.
RESULTS: Since February 2014, 269 stroke telemedicine consultations with 12 neurologists have occurred. Retention on the roster has varied between 1 and >4 years. Overall, neurologists reported benefits of participation, as they were addressing health equity gaps for rural patients. Negative effects were the unpredictability of consultations impacting on their personal life, the mixed level of experience of colleagues initiating the consult and not knowing patient outcomes since follow-up communication was not routine.
CONCLUSIONS: Insights into workforce experience and satisfaction were identified to inform strategies to support specialists to adapt to the disruptive innovation of telemedicine.
© The Author(s) 2015.

Entities:  

Keywords:  Remote consultation; disruptive innovation; teleconsulting; telemedicine

Mesh:

Year:  2015        PMID: 26556058     DOI: 10.1177/1357633X15610722

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  5 in total

1.  Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ).

Authors:  Stephen J Nicholls; Mark Nelson; Carolyn Astley; Tom Briffa; Alex Brown; Robyn Clark; David Colquhoun; Robyn Gallagher; David L Hare; Sally Inglis; Michael Jelinek; Adrienne O'Neil; Rosy Tirimacco; Margarite Vale; Julie Redfern
Journal:  Heart Lung Circ       Date:  2020-04-30       Impact factor: 2.975

2.  Emergency physicians' role in telemedicine care during the coronavirus disease pandemic: Experiences from Taiwan.

Authors:  Chien-Ming Chu; Tsung-Hsi Wang; Hsin-Chung Lee; Chaou-Shune Lin; Cho-Chao Feng
Journal:  Emerg Med Australas       Date:  2021-01-21       Impact factor: 2.151

3.  Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).

Authors:  Anthony C Smith; Emma Thomas; Centaine L Snoswell; Helen Haydon; Ateev Mehrotra; Jane Clemensen; Liam J Caffery
Journal:  J Telemed Telecare       Date:  2020-03-20       Impact factor: 6.184

4.  Evaluating the Immediate Response of Country-Wide Health Systems to the Covid-19 Pandemic: Applying the Gray Incidence Analysis Model.

Authors:  Tehmina Fiaz Qazi; Muhammad Zeeshan Shaukat; Abdul Aziz Khan Niazi; Abdul Basit
Journal:  Front Public Health       Date:  2021-07-15

5.  Integrating acute stroke telemedicine consultations into specialists' usual practice: a qualitative analysis comparing the experience of Australia and the United Kingdom.

Authors:  Kathleen L Bagot; Dominique A Cadilhac; Christopher F Bladin; Caroline L Watkins; Michelle Vu; Geoffrey A Donnan; Helen M Dewey; Hedley C A Emsley; D Paul Davies; Elaine Day; Gary A Ford; Christopher I Price; Carl R May; Alison S R McLoughlin; Josephine M E Gibson; Catherine E Lightbody
Journal:  BMC Health Serv Res       Date:  2017-11-21       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.